At a glance
- Depends onMidstream position: 6 outgoing, 8 incoming connections
- ScaleRevenue is $2.24M, lower than 95% of all stocks globally
- PositionOperating margin is -3072.1%, lower than 95% of its Medical Devices peers (median 7.8%)
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
The statements on file don't all cover the same year: income statement FY2025, balance sheet FY2023, cash-flow statement FY2025. Each figure below is labelled with the year it comes from.
Financials view
Market Capitalization
562.64MUSDvs all stocks (USD)
Revenue (TTM)
2.24MUSDvs all stocks (USD)
52-Week Change
10.52%vs all stocks
Forward Annual Dividend Yield
0.00%vs all stocks
Market Capitalization
562.64MUSDvs all stocks (USD)
Enterprise Value
318.82MUSDvs all stocks (USD)
Forward P/E
-5.09xvs Medical Devices peers
Price to Book (MRQ)
2.27xvs Medical Devices peers
Enterprise to Revenue
142.20xvs Medical Devices peers
Enterprise to EBITDA
-3.05xvs Medical Devices peers
Gross Margin
76.91%vs Medical Devices peers
Operating Margin
-3072.05%vs Medical Devices peers
Return on Assets (TTM)
-42.51%vs Medical Devices peers
Return on Equity (TTM)
-74.65%vs Medical Devices peers
Revenue (TTM)
2.24MUSDvs all stocks (USD)
Revenue per Share (TTM)
0.0350USDUpdated Oct 26, 2026Quarterly Revenue Growth
63.30%vs Medical Devices peers
Gross Profit (TTM)
1.68MUSDvs all stocks (USD)
EBITDA (TTM)
-104.50MUSDvs all stocks (USD)
Net Income (TTM)
-103.56MUSDvs all stocks (USD)
Quarterly Earnings Growth (YoY)
63.27%vs Medical Devices peers
Operating Cash Flow (TTM)
-86.26MUSDvs all stocks (USD)
Levered Free Cash Flow (TTM)
-51.13MUSDvs all stocks (USD)
Forward Annual Dividend Yield
0.00%vs all stocks
Trailing Annual Dividend Rate
0.00USDUpdated Oct 26, 2026Trailing Annual Dividend Yield
0.00%vs all stocks
Payout Ratio
0.00%vs Medical Devices peers
Minority Interest (Equity)
-402.83KUSDFY2023 · Dec 31, 2023Revenue
1.91MUSDFY2025 · Dec 31, 2025Cost of Goods Sold
569.00KUSDFY2025 · Dec 31, 2025Gross Profit
1.34MUSDFY2025 · Dec 31, 2025Operating Income
-94.14MUSDvs all stocks (USD)
Pre-tax Income
-94.22MUSDFY2025 · Dec 31, 2025Income Tax Expense
0.00USDFY2025 · Dec 31, 2025Net Income
-94.22MUSDFY2025 · Dec 31, 2025EBIT
-94.15MUSDFY2025 · Dec 31, 2025EBITDA (Income Statement)
-91.77MUSDFY2025 · Dec 31, 2025Research & Development
69.12MUSDFY2025 · Dec 31, 2025Selling, General & Administrative
26.12MUSDFY2025 · Dec 31, 2025Other Operating Expenses
242.00KUSDFY2025 · Dec 31, 2025Non-operating Interest Income
709.00KUSDFY2025 · Dec 31, 2025Non-operating Interest Expense
73.00KUSDFY2025 · Dec 31, 2025EPS (Basic)
-2.55USDFY2025 · Dec 31, 2025EPS (Diluted)
-2.55USDFY2025 · Dec 31, 2025Basic Shares Outstanding
36.91MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
36.91MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
-94.22MUSDFY2025 · Dec 31, 2025Minority Interests (P&L)
81.00KUSDFY2025 · Dec 31, 2025Operating Cash Flow
-77.80MUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
12.58MUSDFY2025 · Dec 31, 2025Starting Profit (CF Statement)
-94.22MUSDFY2025 · Dec 31, 2025Depreciation & Amortization
1.66MUSDFY2025 · Dec 31, 2025Stock-based Compensation
7.78MUSDFY2025 · Dec 31, 2025Other Non-cash Items
-29.00KUSDFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-515.00KUSDFY2025 · Dec 31, 2025Change in Accounts Payable (CF)
6.42MUSDFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
362.00KUSDFY2025 · Dec 31, 2025Net Intangibles (CF)
1.36MUSDFY2025 · Dec 31, 2025Long-term Debt Issuance
0.00USDFY2025 · Dec 31, 2025Long-term Debt Payments
-1.24MUSDFY2025 · Dec 31, 2025Other Financing Charges
-4.03MUSDFY2025 · Dec 31, 2025Net Financing Cash Flow
20.55MUSDFY2025 · Dec 31, 2025Shares Outstanding
97.41MSharesUpdated Oct 26, 2026Float Shares
65.99MSharesUpdated Oct 26, 2026Shares Short
6.67MSharesUpdated Oct 26, 2026Short Ratio
9.07daysvs all stocks
Short % of Shares Outstanding
9.78%vs all stocks
% Held by Insiders
16.48%vs all stocks
% Held by Institutions
71.88%vs all stocks
Total Cash (MRQ)
256.87MUSDvs all stocks (USD)
Total Cash per Share (MRQ)
2.64USDUpdated Oct 26, 2026Total Debt (MRQ)
3.32MUSDvs all stocks (USD)
Total Debt to Equity (MRQ)
0.0132xvs Medical Devices peers
Current Ratio (MRQ)
14.20xvs Medical Devices peers
Book Value per Share (MRQ)
2.58USDUpdated Oct 26, 2026Total Assets
30.53MUSDvs all stocks (USD)
Total Current Assets
24.22MUSDFY2023 · Dec 31, 2023Total Liabilities
11.63MUSDFY2023 · Dec 31, 2023Total Non-current Assets
6.31MUSDFY2023 · Dec 31, 2023Total Non-current Liabilities
2.17MUSDFY2023 · Dec 31, 2023Total Current Liabilities
9.46MUSDFY2023 · Dec 31, 2023Cash
13.01MUSDFY2023 · Dec 31, 2023Cash Equivalents
8.01MUSDFY2023 · Dec 31, 2023Cash & Cash Equivalents
21.03MUSDFY2023 · Dec 31, 2023Accounts Receivable
407.56KUSDFY2023 · Dec 31, 2023Inventory
442.35KUSDFY2023 · Dec 31, 2023Accounts Payable
3.14MUSDFY2023 · Dec 31, 2023Short-term Debt
668.92KUSDFY2023 · Dec 31, 2023Other Current Liabilities
922.68KUSDFY2023 · Dec 31, 2023Long-term Debt
926.78KUSDFY2023 · Dec 31, 2023Other Non-current Liabilities
93.84KUSDFY2023 · Dec 31, 2023Common Stock (Book)
217.33MUSDFY2023 · Dec 31, 2023Retained Earnings
-200.10MUSDFY2023 · Dec 31, 2023Total Shareholders' Equity
18.90MUSDvs all stocks (USD)
52-Week Low
3.30USDUpdated Oct 26, 202652-Week High
11.05USDUpdated Oct 26, 202652-Week Change
10.52%vs all stocks
50-Day MA
7.89USDUpdated Oct 26, 2026200-Day MA
7.35USDUpdated Oct 26, 2026Avg 10-Day Volume
1.39MSharesUpdated Oct 26, 2026Avg 30-Day Volume
1.27MSharesUpdated Oct 26, 2026Diluted EPS (TTM)
-1.95USDUpdated Oct 26, 2026Other Income / Expense
-725.00KUSDFY2025 · Dec 31, 2025Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Operating margin is -3072.1%, lower than 95% of its Medical Devices peers (median 7.8%)Significant
Operating margin: -30.72Industry median: 0.08Industry P5: -0.68Peers compared: 105
Return on equity is -74.7%, lower than 95% of its Medical Devices peers (median 3.2%)Significant
Return on equity: -0.75Industry median: 0.03Industry P5: -0.74Peers compared: 105
Current ratio is 14.2×, higher than 95% of its Medical Devices peers (median 3.82×)Significant
Current ratio: 14.20Industry median: 3.82Industry P95: 11.74Peers compared: 105
Financial Health
Low earnings qualitySignificant
Earnings Quality Score: -0.76
Supply Chain
Midstream position: 6 outgoing, 8 incoming connectionsNotable
Outgoing: 6.00Incoming: 8.00
High connectivity hub: 14 industry connectionsNotable
Total Connections: 14.00
Scale
Revenue is $2.24M, lower than 95% of all stocks globallySignificant
Revenue (USD): 2,242,000Global P5: 37,231,057.061
Companies that share the same coordination system — how they create, deliver, or capture value.
Beijing Science Sun Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Henan Taloph Pharmaceutical Co. Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Puma Biotechnology Inc.
Tier 1ProductionApproval-Gated PipelineRule
Tibet Weixinkang Medicine Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Hainan Shuangcheng Pharmaceuticals Co. Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Zeria Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
MiMedx Group, Inc.
Tier 1ProductionApproval-Gated PipelineRule
Assure Tech Hangzhou Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Newland Pharmaceuticals Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Ningbo David Medical Device Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow